Adlai Nortye (ANL) Expected to Announce Quarterly Earnings on Thursday

Adlai Nortye (NASDAQ:ANL) is projected to announce its Q2 2026 resultson Thursday, August 6th. Analysts expect the company to announce earnings of ($0.1333) per share and revenue of $3.95 million for the quarter. Investors may visit the the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Friday, August 7, 2026 at 4:00 PM ET.

Adlai Nortye Stock Performance

Shares of NASDAQ ANL opened at $12.38 on Thursday. The stock’s 50 day moving average price is $11.02 and its two-hundred day moving average price is $9.87. Adlai Nortye has a 52-week low of $0.88 and a 52-week high of $17.25.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on ANL shares. JonesTrading started coverage on Adlai Nortye in a report on Thursday, May 14th. They issued a “buy” rating and a $22.00 price target for the company. HC Wainwright raised their price objective on Adlai Nortye from $16.00 to $20.00 and gave the stock a “buy” rating in a research note on Monday, April 20th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Adlai Nortye in a report on Tuesday, July 14th. Oppenheimer started coverage on shares of Adlai Nortye in a research note on Thursday, May 28th. They set an “outperform” rating and a $32.00 target price for the company. Finally, Cantor Fitzgerald initiated coverage on shares of Adlai Nortye in a report on Monday, June 22nd. They set an “overweight” rating on the stock. Five research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Adlai Nortye has a consensus rating of “Moderate Buy” and a consensus target price of $24.25.

Adlai Nortye Company Profile

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.